• Subscribe
    • ENG
    • SWE
Cinclus Pharma Cinclus Pharma
  • ENG
  • SWE
  • This is Cinclus Pharma
    • This is Cinclus Pharma

      Company History

      Company strategy

      Work with us

      Licenced partners

      Corporate Governance

      Management team

      Board of directors

      General meetings

      Financial reports

    • Company History
    • Company strategy
    • Work with us
    • Licenced partners
    • Corporate Governance
  • Our science
    • Our science

      About Gerd

      Patient Story - Life with GERD

      Patient Story - Everyday life with GERD

      Linaprazan glurate

      PPIs versus P-CABs

      Development strategy

      Clinical development

    • About Gerd
    • Linaprazan glurate
    • Development strategy
    • Clinical development
    • Governance

      Corporate Governance Reports

      General Meetings

      2022

      Board of directors

      The work of the board

      Board committees

      Management

      Nomination Committee

      Remuneration

      Auditing

      Articles of Association

    • Investors

      The Share

      Ownership

      Reports & Presentations

      Interim Reports

      Annual Reports

      Presentations

      IPO

      Press releases

      Calendar

  • Media
    • Media

      Press releases

      News

      Subscribe

      Media gallery

      People

      Logotypes

    • Press releases
    • News
    • Subscribe
    • Media gallery
  • Contact
  • Subscribe
  • Home /
  • Media /
  • Press releases /
  • Press page
Back to press releases
Subscribe
Cinclus Pharma

Cinclus Pharma Holding AB (publ)
Kungsbron 1
Level 3, Elevator G
111 22 Stockholm
SWEDEN

Phone: +46 8-133310
E-mail: info@cincluspharma.com

Navigate

  • This is Cinclus Pharma
  • Our science
  • Media
  • Contact

Join our network


© CINCLUS PHARMA 2023Privacy policy